Discontinued — last reported Q4 '22
High levels of goodwill relative to total assets may indicate a high reliance on past acquisitions, increasing sensitivity to future impairment charges.
This metric represents the total unamortized goodwill balance associated with the North American segment, reflecting the...
A standard balance sheet item for all public companies; peers in the pharmaceutical sector typically show significant goodwill due to industry-wide consolidation.
vtrs_segment_north_america_segment_goodwill| Q4 '22 | |
|---|---|
| Value | $3.61B |